Gamifant الاتحاد الأوروبي - المالطية - EMA (European Medicines Agency)

gamifant

swedish orphan biovitrum ab (publ) - emapalumab - immune system diseases - gamifant is indicated for the treatment of paediatric patients aged under 18 years with primary haemophagocytic lymphohistiocytosis (hlh).

Rheumapain- F Viên nang cứng فيتنام - الفيتنامية - BỘ Y TẾ (CỤC QUẢN LÝ DƯỢC)

rheumapain- f viên nang cứng

công ty tnhh dược phẩm fito pharma - hy thiêm ; thương nhĩ tử ; dây đau xương ; thổ phục linh ; hà thủ ô đỏ chế ; thiên niên kiện ; huyết giác ; bột mịn dược liệu gồm: hà thủ ô đỏ chế ; thổ phục linh ; hy thiêm - viên nang cứng - 760mg; 400mg; 400mg; 320mg; 320mg; 300mg; 300mg; 80mg; 80mg; 40mg

Gamifant الاتحاد الأوروبي - السلوفانية - EMA (European Medicines Agency)

gamifant

swedish orphan biovitrum ab (publ) - emapalumab - immune system diseases - gamifant is indicated for the treatment of paediatric patients aged under 18 years with primary haemophagocytic lymphohistiocytosis (hlh).

Gamifant الاتحاد الأوروبي - التشيكية - EMA (European Medicines Agency)

gamifant

swedish orphan biovitrum ab (publ) - emapalumab - immune system diseases - gamifant is indicated for the treatment of paediatric patients aged under 18 years with primary haemophagocytic lymphohistiocytosis (hlh).

Gamifant الاتحاد الأوروبي - السويدية - EMA (European Medicines Agency)

gamifant

swedish orphan biovitrum ab (publ) - emapalumab - immune system diseases - gamifant is indicated for the treatment of paediatric patients aged under 18 years with primary haemophagocytic lymphohistiocytosis (hlh).